This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Cameco Posts Strong Q2 Revenue Gains: Will Momentum Last Through 2025?
by Zacks Equity Research
CCJ's uranium sales volumes rose 40% in Q2, driving a 47% revenue jump as fixed-price contracts offset spot price weakness.
Cameco (CCJ) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Cameco (CCJ) delivered earnings and revenue surprises of +41.67% and +0.49%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Should You Buy, Sell or Hold CCJ Stock Before Q2 Earnings Release?
by Madhurima Das
Cameco is set to post sharply higher Q2 revenues and EPS, but an earnings beat may remain out of reach.
Cameco Corporation (CCJ) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Cameco (CCJ). This makes it worthwhile to examine what the stock has in store.
How Should Investors Approach MIR Stock Before Q2 Earnings?
by Maharathi Basu
MIR's Q2 results may ride on nuclear demand and medical growth, but trade risks could be a dampener.
UUUU vs. CCJ: Which Uranium Stock is the Better Buy Now?
by Madhurima Das
Energy Fuels ramps uranium output and rare earths while outpacing Cameco in stock gains and long-term growth potential.
Cameco (CCJ) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Cameco (CCJ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Cameco (CCJ) Outpaced the Stock Market Today
by Zacks Equity Research
Cameco (CCJ) closed at $79.15 in the latest trading session, marking a +1.6% move from the prior day.
Centrus Energy Delivers Steady Revenue Growth: Is It Sustainable?
by Madhurima Das
LEU revenues soars 67% in Q1 2025 as SWU prices and volumes surged; HALEU momentum and backlog point to strong tailwinds ahead.
Can Cameco Sustain Its Strong Revenue Growth Through 2025?
by Madhurima Das
CCJ forecasts CAD 3.3-3.55 billion in 2025 revenues, fueled by pricing power and rising fuel services demand.
Is It Worth Investing in Cameco (CCJ) Based on Wall Street's Bullish Views?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Cameco (CCJ) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Why Investors Need to Take Advantage of These 2 Basic Materials Stocks Now
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Cameco (CCJ) Rises Higher Than Market: Key Facts
by Zacks Equity Research
Cameco (CCJ) closed the most recent trading day at $77.91, moving +2.26% from the previous trading session.
Nuclear's Moment: Securing US AI Supremacy
by Andrew Rocco
The race for AI supremacy is intrinsically linked to energy production capabilities. If the US wants to win the AI race, it will have to embrace nuclear in a big way.
Cameco Gains 41.5% YTD: Should You Buy, Sell or Hold the Stock?
by Madhurima Das
CCJ soars 41.5% YTD, backed by its upbeat uranium output guidance, bullish Westinghouse gains and long-term nuclear demand trends.
Centrus Energy Soars 197% YTD: Buy, Sell or Hold the Stock?
by Madhurima Das
LEU soars 197% year to date as it advances HALEU production, books a $3.8B backlog and rides strong Q1 results.
Can Cameco Deliver on Its Uranium Production Targets for 2025?
by Madhurima Das
CCJ lifts Q1 uranium output by 3% and holds firm on 2025 outlook despite JV Inkai's temporary shutdown.
Cameco (CCJ) Stock Slides as Market Rises: Facts to Know Before You Trade
by Zacks Equity Research
In the most recent trading session, Cameco (CCJ) closed at $70.82, indicating a -1.02% shift from the previous trading day.
UUUU Gains 36% in the Past 3 Months: Buy, Sell or Hold the Stock?
by Madhurima Das
Energy Fuels is up 36% in three months on strong uranium output, but a stretched valuation and 2025 loss forecast raise red flags.
Mirion Technologies Up 59.2% in 3 Months: Is the Stock Still a Buy?
by Maharathi Basu
Mirion Technologies surges 59.2% in three months, but valuation concerns and macro headwinds raise caution for new buyers.
Cameco (CCJ) Laps the Stock Market: Here's Why
by Zacks Equity Research
In the closing of the recent trading day, Cameco (CCJ) stood at $73.45, denoting a +2.5% move from the preceding trading day.
Investing in AI-Fueled Nuclear Resurgence
by Neena Mishra
Nuclear power emerges as a potential solution for tech giants' AI energy needs.
Surging Clean Energy Demand Sparks Renewed Focus on Nuclear Stocks
by Jewel Saha
For investors aiming to build a nuclear-focused portfolio, companies like Entergy, Dominion Energy, and Constellation Energy present compelling opportunities.
Cameco (CCJ) Stock Declines While Market Improves: Some Information for Investors
by Zacks Equity Research
In the latest trading session, Cameco (CCJ) closed at $73.27, marking a -1.6% move from the previous day.
Cameco (CCJ) Sees a More Significant Dip Than Broader Market: Some Facts to Know
by Zacks Equity Research
Cameco (CCJ) closed at $68.27 in the latest trading session, marking a -2.01% move from the prior day.